Related Experiment Video
Updated: Aug 30, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression
MiYoung Lee1, Matthew J Daniels, Ashok R Venkitaraman
1CR UK Department of Oncology and the Medical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK.
Abstract:
The breast cancer susceptibility protein, BRCA2, preserves chromosomal stability through roles in the repair of DNA double-strand breaks, and possibly, cell division. Post-translational modifications that may coordinate these functions remain poorly characterized. Here, we report that BRCA2 is a substrate for the mitotic Polo-like kinase, Plk1. BRCA2 undergoes phosphorylation in cells synchronously passing through the G2/M phases of cell cycle, when Plk1 expression and activity are maximal. Depletion of Plk1 by RNA interference suppresses BRCA2 modification. BRCA2 and Plk1 interact with one another in cell lysates, through a conserved region in BRCA2, which spans the eight BRC repeat motifs essential for its function in DNA repair. Within this region, residues positioned between BRC repeats--but not the repeat motifs themselves--are phosphorylated by Plk1. Interestingly, Plk1-mediated modification of BRCA2 during the G2/M phases is inhibited by treatment with the radiomimetic agent, adriamycin. Thus, our findings define a regulatory circuit for BRCA2 phosphorylation by Plk1 that is responsive to DNA damage as well as mitotic progression.
Insights
Researchers found that the breast cancer protein BRCA2 is phosphorylated by the mitotic kinase Plk1 during cell division. This Plk1-mediated BRCA2 modification is responsive to DNA damage and mitotic progression.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- BRCA2 is crucial for chromosomal stability and DNA repair.
- Post-translational modifications of BRCA2 are not well understood.
- Polo-like kinase 1 (Plk1) is a key regulator of mitosis.
Purpose of the Study:
- To investigate the role of Plk1 in BRCA2 regulation.
- To characterize the post-translational modification of BRCA2 by Plk1.
Main Methods:
- Cell synchronization and treatment with RNA interference to deplete Plk1.
- Co-immunoprecipitation to assess BRCA2-Plk1 interaction.
- Analysis of BRCA2 phosphorylation sites within the BRC repeat region.
Main Results:
- BRCA2 is phosphorylated by Plk1 during the G2/M cell cycle phases.
- Plk1 depletion inhibits BRCA2 phosphorylation.
- BRCA2 and Plk1 interact via a conserved region in BRCA2.
- Plk1 phosphorylates residues between BRC repeats.
- Adriamycin treatment inhibits Plk1-mediated BRCA2 phosphorylation.
Conclusions:
- A regulatory circuit involving Plk1-mediated phosphorylation of BRCA2 is identified.
- This circuit is sensitive to both mitotic progression and DNA damage.
- Findings provide new insights into BRCA2 regulation and its role in maintaining genomic integrity.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks
Negative Regulator Molecules
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

